Almac Sciences has completed a £5m investment in a new two-storey centre for biocatalysis, flow chemistry technologies and peptide research and development.
The business, which is part of the wider Almac Group, is also currently recruiting for 20 additional staff.
The technology centre is located at the Group’s global headquarter campus in Craigavon and consists of 32 fume hoods, an engineering workshop for tooling and has capacity to accommodate up to 100 employees.
The completion of this new facility comes months after Almac announced its multi-million pound investment to further develop a programme establishing IN Silico Informed metaGenomic Harvesting Technology (INSIGHT).
RELATED: Almac ranked number 5 on Ulster Business top 100 companies list
Professor Tom Moody, Vice President of Technology Development and Commercialisation at the firm said: “The investment in this new, state-of-the-art facility has been critical to support the rapid expansion of our innovative technology offering across different disciplines.
"As our technology evolves, we are experiencing an ever-increasing pipeline of projects taking advantage of our integrated offering from development through to manufacture.
"It is an exciting time to be at Almac as our technology success breeds success. We look forward to driving innovation for our clients in this new centre.”
The next phase of development is currently underway with further announcements expected in the coming months.
RELATED: Almac Sciences awarded £2m grant for enzyme discovery biotech
Source: Almac press release
